Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

By sjmartinez • May 3, 2023

Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold AM, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology (Oxford). 2023 May 2;62(5):1877-1886. doi: 10.1093/rheumatology/keac557. PMID: 36173318; PMCID: PMC10152284.

Tags: connective tissue disease interstitial lung disease, Publications, Pulmonary, Critical Care & Sleep Medicine, systemic sclerosis associated interstitial lung disease subsets, systemic sclerosis interstitial lung disease

Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain

Rodriguez A, Zeng C, Hays RD, Herman PM, Edelen MO. Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with[...]

Diabetic Cardiomyopathy: What Clinicians Should Know

Smati H, Qadeer YK, Rodriguez M, Moras E, Fonarow GC, Isaacs SD, Marwick TH, Krittanawong C. Diabetic Cardiomyopathy: What Clinicians Should Know. Am J Med.[...]

Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics

Fonarow GC, Udelson JE, Yancy CW. Heart Failure With Preserved Ejection Fraction-A Role for Invasive Hemodynamics. JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3764. Epub ahead[...]